PhD+ Commercialization 2: Starting up & staging risks


This is the second session of PhD Plus Commercialization skills series

How does a company "start" and how does ownership take shape for the founders? How do founders and investors “tease out” the risk/uncertainties along the way, and how do their respective ownership stakes change? The early history of the relationship between Genentech and VC Kleiner Perkins will provide the story supporting our discussion.


David Touve, Senior Director, Applied Innovations and New Ventures, Batten Institute, Darden School of Business


Register here by Friday, Jan 28

Core Module Sub Categories